– CANADA, Mississauga – MedX Health Corp. (TSX: MDX), a global leader in teledermatology, today announced the appointments of Stephen Lockyer and Ed Ho to its Board of Directors, bringing many years and wide-ranging business and entrepreneurial experience.
“The Board looks forward to the invaluable expertise and counsel that both Mr. Lockyer and Mr. Ho will bring to the Company, especially at a point where MedX’s SIAscopy technology and DermSecure platform are being launched widely across Canada,” said Board Chairman, Ken McKay.
The company also announced that David Hennigar has been appointed as Vice-Chairman.
MedX also announced the retirement of Mr. Wayne Cockburn from the Board.
About Stephen Lockyer
Stephen Lockyer is the President and Owner of Armshore Investments Limited, based in Nova Scotia, a venture capital investor in real estate and early-stage technology companies. Mr. Ho, a Chartered Financial Analyst, has years of experience as a Portfolio Manager with a major mutual fund, covering diverse mandates, including venture capital, tax strategies, and management of both small-cap and large-cap investment funds.
About MedX Health Corp.
MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy on the DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is also embedded in its products SIAMETRICS, SIMSYS, and MoleMate, which MedX manufactures in its ISO13485-certified facility. SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain-free, non-invasive manner, with its software that creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration, and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union, Brazil, and Turkey.
Source: https://www.medxhealth.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.